MedTrace Logo

Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease

NCT03211260 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-09-12

No results posted yet for this study

Summary

Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes falls, and impairs quality of life. Therapeutic options for this symptom are limited and of limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive sensitivity is likely to play a role and recent studies have reported that high-frequency microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits and could be considered a valuable treatment strategy. However, evidence is not available. The present study was designed to collect preliminary evidence of efficacy of a vibrotactile device (Equistasi) for the treatment of FOG.

Conditions

  • Freezing of Gait
  • Parkinson Disease

Interventions

DEVICE

EQUISTASI

Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.

Sponsors & Collaborators

  • Grisons Foundation for Parkinson's Disease

    collaborator OTHER

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER

  • ASST Gaetano Pini-CTO

    lead OTHER

Principal Investigators

  • Gianni Pezzoli, MD · Centro Parkinson, ASST Gaetano Pini-CTO di Milano

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-11
Primary Completion
2019-07-19
Completion
2019-07-19

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211260 on ClinicalTrials.gov